DOW-UAP-D136 — AAWSAP DIRD, Biosensors and BioMEMS: A Survey of the Present Field, March 2010
File DOW-UAP-D136 is a declassified pdf from Department of War, recording an incident dated 3/31/10 at Las Vegas, Nevada, published in Release 06 (2026-09-18). This page carries the original file, its official summary and its full text.
- File
- DOW-UAP-D136
- Agency
- Department of War
- Incident date
- 3/31/10
- Location
- Las Vegas, Nevada
- Released in
- Release 06 (2026-09-18)
- File type
Topics: AAWSAP & DIRDs
This document is a Defense Intelligence Reference Document (DIRD), a technical reference format used by the Defense Intelligence Agency (DIA) to capture baseline knowledge on a specific topic for later analytic use. DIRDs are best understood as reference and synthesis products rather than as original research. It is one of 38 DIRDs produced under the Advanced Aerospace Weapon System Applications Program (AAWSAP) between 2009 and 2011. Because AAWSAP’s scope permitted a broad range of supporting topics, not every DIRD in the series directly concerns aerospace systems or future threat assessment. The following summary reflects the DIRD’s scope and framing at the time of writing and should not be read as implying current validation of the concepts discussed.
This DIRD surveys biosensors and BioMEMS, a broad class of miniature biomedical devices that combine microscale engineering with sensing, fluid handling, stimulation, or drug-delivery functions. The report reviews major application areas including implantable blood-chemistry sensors, neural interfaces, neurostimulation, drug-delivery pumps, microfluidic systems, and emerging nanoscale extensions of the field, while emphasizing that miniaturization can improve sensitivity and enable functions that are difficult or impossible at larger scales. However, it also makes clear that practical development is constrained by biocompatibility, long-term stability, sensor drift, device degradation inside the body, and the high regulatory burden associated with implantable medical systems. The document presents BioMEMS as a rapidly growing and productive field whose future advances are likely to come through continued improvements in fabrication, materials, and reliability.
Open original file · WAR.GOV page
TL;DR
Even Vegas 2010 had more flashing lights than these biosensors.
- DIRD D136, DoW pdf, March 2010, Las Vegas NV – technical survey under AAWSAP.
- Reviews biosensors, BioMEMS, implantable sensors, neural interfaces, microfluidics, NASA space uses.
- No UAPs reported.
AI summary
A classified defense document titled "Biosensors and BioMEMS: A Survey of the Present Field," prepared by the Defense Intelligence Agency's Acquisition Support Division, dated March 2010. The document discusses biomedical micro-electromechanical systems, their applications, and related technologies. It covers devices developed at Arizona State University, including neural interfaces, blood glucose sensors, and microfluidics, as well as medical uses like insulin pumps and in-vivo pH monitoring. The text describes oxygen and glucose sensors, MEMS fabrication, and challenges in long-term implantability. It also addresses MEMS glucose sensors, thermopile technology, and applications in biosensors and neuroprosthetics. The document includes biomedical applications such as electrode arrays, brain-machine interfaces, and wireless implantable systems. It discusses bioMEMS applications like retinal implants, neurostimulators, and microfluidic devices, along with power methods and lab-on-a-chip technologies. Additionally, it covers microfluidic systems and microcantilever biosensors developed for NASA space applications, including automated cell culture and detection of biomarkers. No UAPs or unidentified objects are reported.
Full text
Page 2
UNCLASSIFIED/ /POR: OPPl@IAL HS& 0Nk¥
Biosensors and BioMEMS: A Survey of the Present Field
Prepared by:
Acquisition Support Division (DW0-3)
Defense Warning Office
Directorate for Analysis
Defense Intelligence Agency
Author:
AAP Person 65
Administrative Note
COPYRI GHT WARNING: Further dissem ination of the photographs in this publ ication is not authorized .
This product is one in a series of adva nced technology reports produced in FY 2009
under t he Defense Intelligence Agency, Defense Warning Office's Advanced Aerospace
Weapon System Applications (AAWSA) Program. Comments or uestions pertaining to
this document shou ld be addressed to!AAP Person 1
, AAWSA Program
Manager, Defense Intelligence Agency, ATTN : CLAR/DWO- 3, Bldg 6000, Washington,
DC 20340-5 100.
1
ii
UNCLASSIFIED/ {FOR OFFICIO! !!ii Qllk¥
Page 3
UNCLASSIFIED/ /POR OFFI
Contents
Introduction.. ..vi
What is BioMEMS? .
Characteristics of BioMEMS 2
Categories of BioMEMS. 3
BioMEMS Micromachines ... 3
Brain-Implanted BioMEMS Micromachine Neuroelectrodes 4
Fluidic BioMEMS ... 6
Drug-Delivery Pumps .
What is a Biosensor? . 9
BioMEMS Implantable Sensors ... 10
MEMS Blood Glucose Sensors ... 13
Commercial Blood Glucose Sensors ..... 14
Enzyme-Based Biosensors... 14
Thermopile Implantable Glucose Sensors ... 15
Neuroengineering by BioMEMS... 20
Bioelectric Events.... .... 20
Bionics and Neurointerfaces.. 22
Bioelectrodes and BioMEMS .... 22
Microelectrode Array Fabrication ... 24
Brain-Machine Interfaces .... 25
Polymer BioMEMS Electrodes ... 26
Retinal Devices Using BioMEMS. 27
Microscale in Therapeutic Neurostimulation.... 30
MEMS in Microfluidics .. 32
Lab Chips •... 33
iii
UNCLASSIFIED/ ∠EOR OEEICTAL USE ONLY
Page 4
UNCLASSIFIED/ / P'O R: OP'P'l@IAL WS& 0Nk¥
NASA Space Applications for Microfluidic Systems ................... .. ....... ......... .... .. 34
Microcantilever MEMs Sensors .. ............ ...... .............. ... ... ...... .... ............ .... ........... 36
Conclusion ....... .............. .... .................... .............. .... ............................................. 39
Figures
Figure 1. Varieties of BioMEMS and Sensors ........................................................... 2
Figure 2. Functional MEMS Micromachines At tached to Sensing Bioelectrodes ... .... 5
Figure 3. Schematic Diagram of a MEMS Motor Complete With a Method of
Converting Oscillatory Motion to Linear Motion ....................................... 5
Figure 4 . Illustration of the Basic Physical Principle of the BioMEMS Motor ..... ...... 6
Figure 5. Close-up Views of the Micr o-Motor Gear .......... .... ................... ... .......... .... 6
Figu r e 6. An Insulin MEMS Pump ............................................................................ 8
Figure 7. An ISFET (Ion Sensitive Field Effect Transistor) Needle-Type pH Sensor
for Monitoring Tissue Physiologic Status ............................................... 11
Figure 8. A Fiber Optical Oxygen Sensor .............................................................. 12
Figure 9. Control of an Insulin-Delivery System by an Implantable Glucose
Sensor ................................................................................................... 13
Figure 10. Glucose Oxidase .................................................................................. 14
Figure 11. An Experimental MEMS Blood Glucose Sensor ..................................... 15
Figure 12. Photomicrograph ................................................................................. 16
Figure 13. A MEMS Thermopile Glucose Sensor .................................................... 17
Figure 14. Illustration of the Thermocouple Principle .......................................... 18
Figure 15. Thermopile Glucose Sensor (left) With Functional Illustration (right)
are Made Using Photolithographic Techniques .................................... 19
Figure 16. Photograph and Illustration of the Thermopile Glucose Sensor in a
Catheter .............................................................................................. 19
Figure 17. A MEMS Biopotential Electrode System ................................................ 20
Figure 18. A Neural Cell Showing Dendritic Inter-Connections That are Electrically
Active With Other Cells........................................................................ 21
Figure 19. A Neuroprosthetic Interface ................................................................ 22
Figure 20. Scanning Electron Micrograph of a Brain Electrode Array Manufactured
From Titanium and Produced by a Process of Electrodischarge
Machining ............................................................................................ 23
Figure 21. Scanning Electron Micrograph of a 1141 Electrode Array Made to Be
Inserted Into the Surface of the Human Brain .................................... 25
Figure 22. Polymer Based Cortical Penetrating Neuroelectrodes Made by Processes
of Thin Film Deposition and RF Etching ............................................... 26
Figure 23. A MEMS Microelectrode Array Implanted Into the Cortex of a Rat Brain
............................................................................................................ 27
Figure 24. A Representation of the Retinal Prosthesis ......................................... 28
Figure 25. A BioMEMS Fabricated 4x4 Microelectrode Retinal Array..................... 28
Figure 26. An Illustration of the Retinal Neuroprosthesis Created by the Boston
Implant Project ................................................................................... 29
Figure 27. Power Transfer by Magnetic Induction to an Implanted BioMEMS Retinal
Prosthesis ........................................................................................... 30
Figure 28. A New Generation of Implantable Neurostimulation Devices Can Pass
Through the Lumen of a Syringe Needle .............................................. 31
Figure 29. Illustration of the Internal Construction of the Ultrasound Powered
Neurostimulator Developed at ASU ..................................................... 32
iv
UNCLASSIFIED/ {FOR OFFICIO! !PEii QDlk¥
Page 5
UNCLASSIFIED/ /P"OR: OP"P"l@IAL HS& 91'11.¥
Figure 30. Microfluidics in Glass........................................................................... 32
Figure 31. Commercial Lab-Chip Devices That Allow Analysis for Biomarkers of
Various Diseases Using On-Chip Electrophoresis in Microscale........... 34
Figure 32. Design of an Automated Cell Culture System for NASA Space
Applications Incorporating Microfluidics and Integrated Optical
Components ........................................................................................ 35
Figure 33. NASA Space Application of Microfluidic Cell Culture System Made by
Micromachining ................................................................................... 36
Figure 34. Principle of a Microcantilever That Bends When It is Loaded With an
Adherent Mass .................................................................................... 37
Figure 35. Scanning Electron Micrograph Showing a Cantilever Beam With a Single
Vaccinia Virus Particle ......................................................................... 38
Figure 36. Antibodies Attached to a Cantilever Array Create Different Specificities
to Substances in Blood That are Indicative of Cancer .......................... 38
V
UNCLASSIFIED/ (FOR OFFICIO! 1155 01!1.¥
Page 6
UNCLASSIFIED/ /P'OR: OP'P'l@IAL WS& 0Nk¥
Biosensors and BioMEMS: A Survey of the Present Field
Introduction
Biomedical sensors and implantable devices employing micro
electromechanical technology will be important to the future of biomedicine.
Once just science fiction, the notion of a bionic man is now becoming a reality
through the application of microscale technologies. Today it is not unusual to
have a friend or family member who has an implantable device, such as a
pacemaker, defibrillator, cochlear implant, biosensor, neurostimulator, or
insulin pump.
We have only seen the beginning of this technology development, and today's
state-of-the-art implantable devices will be seen as crude and cumbersome
tomorrow. With the rapid pace of development, it is probable that within the
next two decades we will have as many medical treatments based on
microdevices as there are pharmaceutical solutions today. This paper
examines some of the most recent advances in the field, as well as the
technologies that are likely to appear in the next few years.
vi
UNCLASSIFIED/ {FOR OFFICIO! !PEii QDlk¥
Page 7
UNCLASSIFIED/ /P'OR: OP'P'l@IAL WS& 0Nk¥
What is BioM EMS?
BioMEMS stands for biomedical micro-_glectro-mechanical ~ystems. It is a name applied
to biological and medical devices that are created using advanced fabrication processes
that allow the devices to be very small relative to comparable devices produced by
traditional techniques. BioMEMS devices can also exploit the microscale to provide new
functions that are not practical or possible in large-scale devices.
The name applies to an exceptionally wide variety of engineered devices that derive
from electrical, mechanical, chemical, and molecular engineering. The name
distinguishes these from nanoMEMS which are submicron in scale such as carbon
nanotube structures.
Recently BioMEMS has become something of a misnomer as many of the latest
technologies are being designed and developed based on nanoscale technologies which
are many times smaller than microscale technologies. While current devices are
manufactured mostly on the microscale, many of the functioning parts and the
materials they operate on are at the nanoscale level.
NanoMEMS for biomedical applications are mostly carbon-based materials that have
emerged as prime materials because of their favorable mechanical and electrical
properties. Carbon-based nanostructures such as graphene exhibit a hig h Young's
modulus (stiffness), high strength, low density, low friction and large surface area. The
low friction of a carbon nanotube allows production of practically frictionless bearings
and has thus been a huge motivation towards applications such as nanomotors. Carbon
nanostructures are much stronger than steel, which allows carbon-based materials to
meet high-stress demands in biomedical applications such as weight-bearing
prosthetics (like hip-joint or bone replacements), where other materials would fail.
The field of BioMEMS encompasses micro devices that are often but not exclusively
made by the same photolithographic techniques used to make computer chips. Their
applications include neuroprosthetics, sensors and actuators, and microchemistry
systems. A microchemistry system, often called a lab on a chip, can analyze chemical
properties of a very small quantity of material such as a tiny blood sample. Advanced
systems can perform several tests on the sample at one time.
There are also drug-delivery systems, miniature hearing aids, artificial retinas, DNA
analysis systems, cancer diagnostics, and an amazing variety of devices which support
the function of the human body. Figure 1 shows some devices that were developed by
the faculty of Biomedical Engineering at Arizona State University.
1
UNCLASSIFIED/ {FOR OFFICIO! !PEii QDlk¥
Page 8
UNCLASSIFIED/ /P'OR: OP'P'l@IAL WS& 0Nk¥
Varieties of BioMEMs and Sensors
---
---·
·-•·
-- -
.I . .I .
-- -· ---·
---·
Figure 1. Varietie.s of BioMEMS and Sensors. These BioMEMS devices were made at Arizona State University
(ASU). They represent many of the areas of BioMEMS research .
CHARACTERISTICS OF BIOMEMS
Conceiving and designing BioMEMS devices requires a different perspective of the
physical world. These devices can operate on principles such as capillary force, van der
Waals forces, and electric-field forces. These forces become relatively strong when the
size scale reaches very small dimensions. In the realm of the very small, the force of
gravity is far less important than electrical charge and viscosity.
From the perspective of microscale devices, engineers need to think about
accomplishing tasks on an extremely subtle scale but with an exceptionally effective
result. BioMEMS employs engineering sciences in ways that are more than just scaling
down familiar devices used in biomedical applications. Rather, employment of new
structures and new materials including polymers and biological components is
necessary. In addition we need to be concerned about things like biocompatibility (the
effect of the device on body tissue) as well as the degradation effects of tissues and
body fluids on the device itself.
Development of a new product that is targeted for implantation into the human body is
particularly expensive due to federal regulation of medical devices. Devices must be
shown to be effective for their intended use, and above all devices must be proved safe.
Bringing a new device to market is not unlike the development of a new drug. In order
2
UNCLASSIFIED/ {FOR OFFICIO! !PEii QDlk¥
Page 9
UNCLASSIFIED/ /P'OR: OP'P'l@IAL WS& 0Nk¥
to gain federal approval there may be biocompatibility issues to resolve, clinical trials to
perform, and Food and Drug Administration (FDA) requirements to satisfy.
CATEGORIES OF BIOMEMS
We divide the BioMEMS field into several subcategories. Some devices are targeted to
be implanted into the human body or are applied to the body. Many of these are being
developed as alternatives to drugs which therapeutically treat illness or disease. There
is also activity in using microscale stimulation devices to treat neurological disorders
such as epilepsy and Parkinson's disease and to treat neurological injuries such as
stroke or trauma to the spinal cord.
Another promising field of research is directed towards integration of the human brain
with microelectrical components. For example implants are being developed which allow
volitional (thought) control of machines. Most of this effort is targeted towards
rehabilitation of individuals who are quadriplegics in order to allow them some control
over their environment.
Then there are devices being developed for clinical applications such as rapid blood
analysis, and t here are those targeted for benchtop biological research. I n this review,
the focus is on specific microscale and MEMS-based devices t hat are used in medicine
and biology .
These include:
•
Micromachines that interface to brain electrodes.
•
Blood glucose sensors.
•
Microfluidics.
•
Neural Interfaces.
•
Neurostimulators.
•
Microbeam sensors.
Several of these technologies have been the subject of research by the present author
and by colleagues at Arizona State University.
BioMEMS Micromachines
Micromachines made by photol ithography are among the most complex and
sophisticated of all MEMS devices. They have seen some application in various forms of
biomedical devices where motion must be achieved with an implantable device. Motion
within the human body by a device is difficult since it implies sliding surfaces, a need
for electrical power, and long term reliability and stability. Biomedical implants are
usually introduced by surgery and so once implanted cannot be easily removed for
servicing.
3
UNCLASSIFIED/ (FOR OFFICIO! P!Sli Qllk¥
Page 10
UNCLASSIFIED/ /P'OR: OP'P'l@IAL WS& 0Nk¥
Only a few BioMEMS applications are well known for implanted devices and these are
used for positioning and repositioning of sensors. A specific example is application to
brain-electrode systems.
BRAIN-IMPLANTED BIOMEMS MICROMACHINE NEUROELECTRODES
There are applications in biomedicine and research where very small electrodes are
implanted into the brain. These microelectrodes are used in the cortex (surface layer)
to detect electrical activity associated with the volitional desire to move some part of
the body. Electrical activity is recorded as a very small change in voltage within the
tissue.
Near the top of the human head and about 2 cm beneath the scalp lie the parts of the
brain where nerve cells (neurons) are found which control the muscles of the body.
Specific locations in the cortex are associated with specific parts of the body. When a
person moves a limb, there can be detected a corresponding electrical activity of these
neurons. Neuroscientists have recorded these signals and developed a kind of map of
the brain that defines what brain ce lls actuate certain muscles of t he body.
An interesting phenomenon occurs in which some of these brain cells become active
even when t here is intent to move a limb but no actua l movement occurs. I n a healthy
person the intent to move can be detected by measurement of microvolt signals from
the brain cells about 120 milliseconds before any muscle movement occurs. In a person
who has lost a limb or has become para lyzed, the intent to move can still be detected in
the brain even though there is no limb movement.
Thus in principle there is an ability to electrically record from the brain and determ ine a
person's intent to move. Monitoring of the brain is accomplished by using an array of
implanted microelectrodes whose signals anticipate movement of specific limbs. These
signals can in turn be used to control machines. This is the idea beh ind advanced
devices that allow quadriplegics to interact with their environment. Signals from
implanted electrodes are used by computers to control robotic actuators.
A problem recording t he signals occurs because the body naturally tends to encapsulate
the electrodes with scar tissue, meaning the electrodes lose electrica l contact with the
neurons. A solution to this problem incorporates a very sma ll electromechan ical
actuator attached to the electrode. This device allows the implanted electrodes to
change their position occasionally in order to continue to monitor neural events. By
moving t he thin rod-like electrode up or down a small distance after several months of
implantation, the useful lifetime of the electrode array can be greatly extended.
The BioMEMS device described here is meant to be implanted under t he skull and on
top of the bra in cortex . It allows fine adjustment of less tha n a millimeter in order to
make sure the electrode system, once implanted, is able to contact the desired bra in
cells even after the electrode has been encapsu lated by scar tissue over t ime.
Figure 2 shows a photomicrograph of a gear-driven micromachine that was made
through collaboration between ASU and Sandia National Laboratories. The device is
driven by an electrostatic vibrating comb motor . Under a microscope it can be seen that
the combs move in an oscill atory fash ion at about 40 Hz when energized . Electrostatic
forces between two blade- like combs a few tens of microns apart are operative with
about 15 volts as the electric field source.
4
UNCLASSIFIED/ {FOR OFFICIO! !PEii QDlk¥
Page 11
UNCLASSIFIED/ /P'OR: OP'P'l@IAL WS& 8NI.¥
The Neural Probe chip enables precise bi-directional positioning of the microelectrodes
in the brain with a step resolution in the order of 8.8 µm. The thermal microactuators
allow for a movement of the microelectrodes of up to 5 mm in either direction making it
suitable for positioning microelectrodes in deep structures of a rodent brain.
The rest of the mechanism converts an oscillatory motion to a linear motion through a
ratchet-type configuration. Figure 3 illustrates the basic unit where there are two comb
like arrays on either side. These generate the actual force. They are connected to a
cross piece that converts oscillatory motion in concert with a spring to a pulsatile linear
motion of the vertical shaft. This connects to some gears which do a mechanical
transformation.
,
~---
Figure 2. Functional MEMS Micromachines Attached
to Sensing Bioelectrodes. The gears have features as
small as 50 microns, less than the size of a period on a
printed page . (Courtesy of Dr. J. Muthuswamy,
Bioengineering Department, ASU)
...
fon•11,
~
Figure 3. Schematic Diagram of a MEMS Motor
Complete With a Method of Converting
Oscillatory Motion to Linear Motion. (Courtesy of
Dr. J. Muthuswamy, Bioengineering Department, ASU)
5
UNCLASSIFIED/ {FOR OFFICIO! !Pfli ODIi.¥
Page 12
UNCLASSIFIED/ /P'OR: OP'P'l@IAL WS& 0Nk¥
Figure 4 illustrates the basic physics where the force is generated. A voltage V, is
applied to the horizontal sliding shaft. There arises an electrical field (shown as the
curved arrow) that tends to pull the shaft into the cavity between the two outer combs.
This is the basic motive force of the device. The force generated by each comb is very
small so there are constructed many sim ilar structures that form a comb-array. All of
the forces act in parallel.
(1)
V
(3)
Figure 4. Illustration of the Basic Physical Principle of the BioMEMS Motor (Muthuswamy et al.)
The device is fabricated by using Sandia's Ultraplanar Multi-level MEMS Technology
(SUMMiTV) process, a 5-layer polysilicon micromachining technology. The layers are
chemically sensitive to different processes and can be selectively removed by etching
with different reagents.
For example silicon can be removed
using an etchant which preferentially
removes silicon only along certain
crystalline planes. Other layers can be
undermined through the use of acids.
The components of the micromachine
are patterned on the silicon using
photoresist masks. A mask is a covering
which prevents parts of the silicon from
being etched away. Figure 5 gives an
idea of the sophistication of this MEMS
fabrication technique.
The end result is that the long rod at
the right of the picture in Figure 3
moves up and down with a speed of
about 1-2 mm per second. The speed
can be adjusted through the number of
teeth designed on the reduction gears.
Figure s. Close-Up Views of the Micro-Motor Gears
(Sandia National Labs)
Single unit recordings were obtained from the somatosensory cortex of adult rats over
a period of three days demonstrating the feasibility of th is technology. This device has
been implanted in rats and its development supported by the neuroprostheses program
of the US National Institutes of Health.
Fluidic BioMEMS
The application of microscale fabrication techniques has allowed the manipulation of
very small volumes of fluids on the nanoliter and even picoliter scales. This allows
6
UNCLASSIFIED/ (FOR OFFICIO! P!Sli Qllk¥
Page 13
UNCLASSIFIED/ /P'OR: OP'Pl@IAL WS& 0NI.¥
chemical processes such as separations, reactions, and analysis to be conducted with
very small amounts of sample.
According to a forecast by the Nexus Task Force, the market for BioMEMS is expected
to reach $18 Billion in 2005. The commercial success of these devices and the technical
potential of other BioMEMS has driven research in a number of areas. As a result, over
the past few years, fluidic BioMEMS devices have become the largest and most diverse
applications of MEMS devices.
Fluidic BioMEMS now include:
•
Drug-delivering neuroprobes.
•
Biosensors (general).
•
Bioreactors.
•
Cell-handl ing devices.
•
Drug-delivery devices.
•
Micro-chromatography systems.
•
Microfluidics.
•
Molecular detection/handling.
•
Neural interface devices.
•
Optical/retinal sensing.
•
Surgical devices.
•
Tissue-handling devices.
There are obviously application overlaps within these devices and some are integrated
with others to create system-level or multi-sensing devices. Applications run the gamut
of the imagination includ ing identification of bacterial or viral agents, drug testing,
home testing, environmental safety and security, and drug-delivery technologies.
DRUG-DELIVERY PUMPS
Drug delivery to the human body for medical therapeutic purposes has long been by
swallowing substances or by injection. However this approach creates rapid rises and
falls in drug concentration in the blood stream because the dose is typically introduced
all at one time. The blood titer of a drug may thus peak at undesirably high levels in an
effort to sustain the drug action over a longer period of time.
Treatment of many medical conditions, such as cancer by chemotherapeutic drugs
would best be accomplished by a steady and long sustained infusion of the drug into
the blood. This would keep the tumor-fighting drug at some optimal concentration and
so make it maximally effective. High levels of chemotherapeutic drug levels in the blood
are toxic and levels that are below some threshold are ineffective.
7
UNCLASSIFIED/ (FOR OFFICIO! P!Sli QDII.¥
Page 14
UNCLASSIFIED/ /P'OR: OP'P'l@IAL WS& 0Nk¥
Methods of creating a more sustained blood concentration of a given drug are desirable
to increase drug effectiveness. Similarly there are other medical applications for
controlled-release drug-delivery systems, such as that for insulin, where it is desirable
to maintain a more sustained dose over a period of hours.
There has been the application of MEMS technologies in the creation of better ways to
deliver drugs to the human body by way of small implantable reservoirs that can slowly
release their drug over a prolonged period of time. Figure 6 shows a MEMS-based
insulin-delivery pump for the treatment of diabetes. This is perhaps one of the largest
applications of BioMEMS in medicine.
Subcutaneous drug delivery
Debiotech p iezoelec ric
in sulin pump
S itzerland
http://lllww.tfebiotech.com/dobiotoch.h
• MEMS technology using Si and glass
biocompatibility
• Precise control of nl volumes
• Prevent under/overdosing and detect occlusions, other problems
• Small size : 114th the size of existing monitors
• Proprietary hermetic packaging
• In he U.S. alone, 60 mill ion people are affec e by diabe es
• 15% of worldwide heal h spending goes award rea ing diabe es .
• 450,000 people now wear ransportable insulin pumps worldwide.
sources: Debiotech
ebsite· Ad vanced Packaging
Figure 6. An Insulin MEMS Pump. An implantable drug-delivery device.
Diabetes is a disorder in wh ich glucose (blood sugar) is not properly taken into the cells
of the body. This process is normally mediated by the hormone insulin, which is
produced by the islet cells of the pancreas. Insulin circu lates in the blood to actuate a
receptor on tissue cells that causes them to uptake glucose from the blood stream. If
there is too little insulin (as in Type 1 diabetes) the cells will not uptake glucose from
the blood, the cell s will starve, and blood sugar levels become too high from
unabsorbed glucose. Alternatively, cell s may not respond properly to normal insulin
levels (as in Type 2 diabetes) and require artificially higher levels of insulin to uptake
glucose. This is ca lled insulin resista nce. In either case, blood insulin levels can be
increased by using insulin injection devices.
Brittle diabetes is a condition where blood glucose levels fluctuate wildly with eating or
fasting causing hyperglycemia (too high a blood glucose-more than about 100 mg
percent) or too low (hypoglycemia-less than about 60 mg percent). Brittle diabetics
8
UNCLASSIFIED/ {FOR OFFICIO! !PEii QDlk¥
Page 15
UNCLASSIFIED/ /P'OR: OP'Pl@IAL WS& 0NI.¥
have a significant problem in controlling their blood sugar and sometimes insulin doses
are not adjusted finely enough or frequently enough to maintain the blood glucose at
healthy levels. This form of diabetes is responsible for fainting (ketoacidosis) and other
serious symptoms such as poor blood circulation to the limbs. Poor circulation can
result in diabetic ulcers and may sometimes necessitate amputation of the limb.
Insulin pumps are often worn by brittle diabetics because a slow infusion of insulin
works better in stabilizing blood glucose levels rather than periodic injections. A belt
worn insulin-delivery system looks something like an old-style audio player. These
systems are typically controlled by a small screw-type pump powered by batteries. The
reservoir carries several milliliters of insulin for dispensing over an extended period of
time. The injection needle is connected (underneath the clothes) to a catheter and then
to the pump. The systems are reasonably effective but are cumbersome and require the
needle to continuously reside subcutaneously in the abdomen.
A MEMS implanted insulin pump is a less cumbersome and perhaps more convenient
means of slowly infusing insulin at a programmed rate. The implanted device is refilled
periodically by introducing a needle through the skin and tissue to a septum in the
device.
The MEMS insulin pump shown in Figure 6 is surgically placed under the skin. It has a
rubber septum on the top for filling with insulin. This implementation has a piezoelectric
element that moves in response to electrical charge. When actuated by a timer the
element oscillates, creating a pressure inside the device that dispenses insulin. The
device is programmable for dispensing at various rates.
Although the implantable MEMS pump was developed for diabetes, the pump has
application to the slow measured delivery of many other drugs including 5-fluoruracil
used for cancer therapy and theophyllne for treatment of asthma.
What is a Biosensor?
A primary application of BioMEMS is in the creation of sensors for blood chemistry and
other biophysical parameters of the human body.
We can define a Biosensor as:
•
A sensor whose application is primarily in the measurement of quantities within a
biological system, such as chemical, electrical, and physical parameters.
•
A sensor incorporating a biological component (enzymes, living cells, antibodies)
typically used to measure chemical concentration. This definition does not require
that the sensor be deployed within a biological system.
The two definitions wh ich are somewhat different have their origin with different
influential investigators who wrote textbooks in the early days of this field. The latter
definition is prevalent in Europe.
A biosensor is normally constructed by immobilizing a biologically active material (such
as an enzyme) onto an electrical sensor that measures a fundamental physical quantity
Previous: DOW-UAP-D135 — AAWSAP DIRD, Antigravity for Aerospace Applications, March 2010 · Next: DOW-UAP-D137 — AAWSAP DIRD, State of the Art and Evolution of High-Energy Lasers, March 2010
Same topic: title & summary match
Same location: Las Vegas, Nevada
- DOW-UAP-D174 — Utah Ranch Investigation Report, April 2010
- DOW-UAP-D166 — MUFON Reports Prepared for BAASS, November 2008
- DOW-UAP-D168 — BAASS Project Management Plan, December 2008
- DOW-UAP-D169 — BAASS Monthly Report, March 2009
- DOW-UAP-D170 — BAASS Monthly Report, April 2009
- DOW-UAP-D171 — BAASS Monthly Report, June 2009
Same period: 2010
- DOW-UAP-D114 — AAWSAP Contract Modification P00003, May 2010
- DOW-UAP-D113 — AAWSAP Contract Modification P00002, February 2010
- DOW-UAP-D115 — AAWSAP Contract Modification P00004, May 2010
- DOW-UAP-D116 — AAWSAP Contract Modification P00005, September 2010
- DOW-UAP-D131 — AAWSAP DIRD, The Role of Superconductors in Gravity Research, March 2010
- DOW-UAP-D133 — AAWSAP DIRD, The Space Communication Implications of Quantum Entanglement and Nonlocality, March 2010
Same release: Release 06
- DOW-UAP-PR159 — Historical Film of Reported UFOs, Utah, 1952
- LLE-UAP-PR001 — Unresolved UAP Report, Colorado, 2023
- LLE-UAP-PR002 — Unresolved UAP Report, Colorado, October 2023
- DOW-UAP-PR133 — Unresolved UAP Report, Middle East, 2025
- DOW-UAP-PR135 — Unresolved UAP Report, Middle East, 2025
- DOW-UAP-PR140 — Unresolved UAP Report, Middle East, 2022
Same agency: DoW
- DOW-UAP-D094 — Analysis of Flying Object Incidents in the United States, 1949
- DOW-UAP-D097 — Project Sign Progress Report, 1948
- DOW-UAP-D084 — US Army-Flying-Saucer-Study 1949
- DOW-UAP-D155 — Air Intelligence Information Report, Saudi Arabia, 1957
- DOW-UAP-D176 — Triangular UAP AARO Memorandum for Record, 2026
- DOW-UAP-D177 — Unresolved UAP Report, Catalina Island, 1955